Spaulding Clinical Research, LLC Wins CRO Leadership Award
Spaulding Clinical Research, LLC (SCR) announced it has been recognized for excellence in clinical research by biopharmaceutical executives surveyed for the Life Science Leader magazine’s 2015 CRO Leadership Awards.
West Bend, WI, May 20, 2015 --(PR.com)-- SCR was named a two-category winner for quality and innovation for the second year in a row, based on survey responses from more than 2,300 industry executives responsible for making or influencing decisions to outsource clinical development programs to contract research organizations (CROs).
“Spaulding Clinical is honored to receive recognition from the biopharmaceutical industry for quality and innovation for the second year in a row,” said Randol Spaulding, Founder and CEO of SCR. “Innovation and quality run deep at Spaulding Clinical and these awards are a testament to our dedicated professionals and the ingenious solutions they strive for every day.”
Life Science Leader developed the annual CRO Leadership Awards in 2012 to honor top performers based on leading industry research conducted by professional market research agency Nice Insight. For this year's program, Life Science Leader narrowed the field of award winners by selecting only those companies that placed in the top 10% of each category.
About Spaulding Clinical Research, LLC
SCR is a global CRO providing Phase I - IV drug development services to the biopharmaceutical industry. Spaulding Clinical Research operates a 165 bed Clinical Pharmacology Unit, a Core ECG Laboratory and provides full Biometrics/Scientific Affairs services.
About the Awards
Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in vetting CRO partners. In response, Life Science Leader developed the CRO Leadership Awards based on industry research conducted by Nice Insight. The awards incorporate common filters used by pharma companies to vet CROs with the added filter of peer feedback. Unlike other industry awards which are given based on a voting or nomination process, the only votes that count towards the CRO Leadership Awards are those of the pharmaceutical and biopharmaceutical companies using CRO services. This helps pharma and biopharma companies focus on potential CRO partners who can handle their projects and are considered reputable in the industry.
“Spaulding Clinical is honored to receive recognition from the biopharmaceutical industry for quality and innovation for the second year in a row,” said Randol Spaulding, Founder and CEO of SCR. “Innovation and quality run deep at Spaulding Clinical and these awards are a testament to our dedicated professionals and the ingenious solutions they strive for every day.”
Life Science Leader developed the annual CRO Leadership Awards in 2012 to honor top performers based on leading industry research conducted by professional market research agency Nice Insight. For this year's program, Life Science Leader narrowed the field of award winners by selecting only those companies that placed in the top 10% of each category.
About Spaulding Clinical Research, LLC
SCR is a global CRO providing Phase I - IV drug development services to the biopharmaceutical industry. Spaulding Clinical Research operates a 165 bed Clinical Pharmacology Unit, a Core ECG Laboratory and provides full Biometrics/Scientific Affairs services.
About the Awards
Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in vetting CRO partners. In response, Life Science Leader developed the CRO Leadership Awards based on industry research conducted by Nice Insight. The awards incorporate common filters used by pharma companies to vet CROs with the added filter of peer feedback. Unlike other industry awards which are given based on a voting or nomination process, the only votes that count towards the CRO Leadership Awards are those of the pharmaceutical and biopharmaceutical companies using CRO services. This helps pharma and biopharma companies focus on potential CRO partners who can handle their projects and are considered reputable in the industry.
Contact
Spaulding Clinical Research, LLC
Tyler Borst
(262) 334-6020
www.spauldingclinical.com
Tyler Borst
(262) 334-6020
www.spauldingclinical.com
Contact
Categories